Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$970K Buy
+10,686
New +$975K 0.68% 43
2025
Q4
$1.43M Buy
11,406
+700
+7% +$89.2K 1.16% 28
2025
Q3
$1.43M Hold
10,706
1.24% 27
2025
Q2
$1.46M Sell
10,706
-249
-2% -$32.8K 1.27% 21
2025
Q1
$1.45M Sell
10,955
-100
-0.9% -$12.7K 1.4% 21
2024
Q4
$1.25M Buy
+11,055
New +$1.28M 1.19% 27

Other funds holding ABT

Maxele Advisors's ABT Position: Q2 2026 in Review

Maxele Advisors opened a new position in Abbott (ABT) in Q2 2026: 10,686 shares worth $970K. The stake represents 0.68% of the portfolio and ranks #43 among its holdings. This is a return to the name: Maxele Advisors previously reported a position in ABT as recently as Q4 2025.

Maxele Advisors first reported a position in ABT in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.46M in Q2 2025. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Maxele Advisors held 10,686 shares of Abbott worth $970K as of Q2 2026.
  • Abbott was a new Maxele Advisors position in Q2 2026.
  • Abbott made up 0.68% of Maxele Advisors's portfolio in Q2 2026, its #43 holding.
  • Maxele Advisors first reported a position in Abbott in Q4 2024 and has held it in 6 quarters since.
  • Maxele Advisors's Abbott position peaked at $1.46M in Q2 2025.
  • 2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Maxele Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.